Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05943119

Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
52 (estimated)
Sponsor
Centre Francois Baclesse · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The patient is randomized to one of the following groups: * Experimental group: Radiotherapy in painting dose on histoscannographic mapping * Control group: standard pan-sinus radiotherapy

Conditions

Interventions

TypeNameDescription
RADIATIONRadiotherapy in painting dose on histoscannographic mappingThe target volumes to be delineated are as follows: * High-risk CTV (Clinical Target Volume), corresponding to all initially invaded areas, as identified by comparison between the operative report and the anatomo-pathological report (ideally with histo-surgical mapping). * Low-risk CTV, corresponding to naso-sinusal structures not initially invaded but at risk of recurrence, and located close to the high-risk target volume, including at least 5 mm around the high-risk volume and excluding non-risk areas (muscle, bone).
RADIATIONStandard pan-sinusal RadiotherapyThe target volumes to be delineated are as follows: * High-risk CTV, including the entire post-operative cavity, * Low-risk CTV, adapted from the recommendations described by Lapeyre (Cancer/Radiotherapy 2005), and including at least 5 mm around the high-risk volume, excluding non-risk areas (muscle, bone).

Timeline

Start date
2024-03-11
Primary completion
2028-01-01
Completion
2029-03-01
First posted
2023-07-13
Last updated
2025-07-28

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05943119. Inclusion in this directory is not an endorsement.